Literature DB >> 33691584

Regulation of DNA duplication by the mTOR signaling pathway.

Zhengfu He1, Peter J Houghton2, Terence M Williams3, Changxian Shen3.   

Abstract

Accurate and complete DNA replication and separation are essential for genetic information inheritance and organism maintenance. Errors in DNA duplication are the main source of genetic instability. Understanding DNA duplication regulation is the key to elucidate the mechanisms and find treatment strategies for human genetic disorders, especially cancer. The mechanistic target of rapamycin (mTOR) is a central regulator of cell growth and proliferation by integrating and processing extracellular and intracellular signals to monitor the well-being of cell physiology. mTOR signaling dysregulation is associated with many human diseases including cancer and diabetes. Emerging evidence has demonstrated that mTOR signaling plays a key role in DNA duplication. We herein review the current knowledge of mTOR signaling in the regulation of DNA replication origin licensing, replication fork progression, and stabilization.

Entities:  

Keywords:  DNA repair; cell cycle; mTOR; DNA replication origin licensing; replication fork progression; replication fork stabilization

Mesh:

Substances:

Year:  2021        PMID: 33691584      PMCID: PMC8098070          DOI: 10.1080/15384101.2021.1897271

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  109 in total

Review 1.  TOR signaling in growth and metabolism.

Authors:  Stephan Wullschleger; Robbie Loewith; Michael N Hall
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

2.  mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells.

Authors:  J Li; W Du; S Zhang; F Guo; M O'Connor; G Thomas; S Kozma; B Zingarelli; Q Pang; Y Zheng
Journal:  Leukemia       Date:  2013-03-29       Impact factor: 11.528

3.  Up-regulation of cyclin-E(1) via proline-mTOR pathway is responsible for HGF-mediated G(1)/S progression in the primary culture of rat hepatocytes.

Authors:  Kiyomasa Oka; Wakana Ohya-Shimada; Shinya Mizuno; Toshikazu Nakamura
Journal:  Biochem Biophys Res Commun       Date:  2013-04-22       Impact factor: 3.575

4.  mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E.

Authors:  Diane C Fingar; Celeste J Richardson; Andrew R Tee; Lynn Cheatham; Christina Tsou; John Blenis
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

5.  The DNA replication and damage checkpoint pathways induce transcription by inhibition of the Crt1 repressor.

Authors:  M Huang; Z Zhou; S J Elledge
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

6.  FANCD2 regulates BLM complex functions independently of FANCI to promote replication fork recovery.

Authors:  Indrajit Chaudhury; Archana Sareen; Maya Raghunandan; Alexandra Sobeck
Journal:  Nucleic Acids Res       Date:  2013-05-08       Impact factor: 16.971

Review 7.  Targeting the ATR-CHK1 Axis in Cancer Therapy.

Authors:  Stuart Rundle; Alice Bradbury; Yvette Drew; Nicola J Curtin
Journal:  Cancers (Basel)       Date:  2017-04-27       Impact factor: 6.639

8.  Initial Steps in Mammalian Autophagosome Biogenesis.

Authors:  Daniel Grasso; Felipe Javier Renna; Maria Ines Vaccaro
Journal:  Front Cell Dev Biol       Date:  2018-10-23

9.  Mammalian EAK-7 activates alternative mTOR signaling to regulate cell proliferation and migration.

Authors:  Joe Truong Nguyen; Connor Ray; Alexandra Lucienne Fox; Daniela Baccelli Mendonça; Jin Koo Kim; Paul H Krebsbach
Journal:  Sci Adv       Date:  2018-05-09       Impact factor: 14.136

10.  ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer.

Authors:  Franklin C Harwood; Ramon I Klein Geltink; Brendan P O'Hara; Monica Cardone; Laura Janke; David Finkelstein; Igor Entin; Leena Paul; Peter J Houghton; Gerard C Grosveld
Journal:  Sci Adv       Date:  2018-09-12       Impact factor: 14.136

View more
  1 in total

1.  Identification of Inhibitors and Drug Targets for Human Adenovirus Infections.

Authors:  Minli Liu; Lefang Jiang; Weihua Cao; Jianguo Wu; Xulin Chen
Journal:  Viruses       Date:  2022-05-04       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.